Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-051408)

Filing Details

Accession Number:: 0001209191-23-051408
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-10-03 16:07:56
Reporting Period:: 2023-09-29

Accepted Time:: 2023-10-03 16:07:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1744749	Jonathan Biller	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp And Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-09-29	408	$350.72	11,179	No	4	F	Direct
Common Stock	Disposition	2023-10-02	610	$346.76	10,569	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	F	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2023.